...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: What's the deal with Zenith?
Reply New Message
Prev Message Back To Forum Threaded View Next Message

KOO - If BoM2 fails, the debt might not be repaid but the RPS's are probably worthless also. If the current debt is paid off which has the IP as security, the IP might then be used for the Zenith loan. In that case, if RVX defaulted, the loan wouldn't be repaid but Zenith would then have the RVX IP.

4 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply